Nutex Health generated $151.7 million in Q4 2025 revenue, down 41.1% year over year primarily due to arbitration claim adjustments and revenue timing differences. Net income attributable to Nutex Health was $11.8 million, and hospital visits increased 6.1% year over year, reflecting higher patient volumes despite revenue volatility.

Nutex Health generated strong Q3 2025 results with revenue growth driven primarily by higher hospital visits and expansion of its facility network. Profitability improved with solid EBITDA generation as the company continued scaling its hospital division operations.

Nutex Health reported record annual revenue of $875.3 million, an 82% increase year-over-year, driven significantly by its hospital division and success in the Independent Dispute Resolution (IDR) process. However, Q4 revenue saw a sharp decline due to a one-time $55 million arbitration true-up for ineligible claims. The company ended the year with a record cash balance of $185.6 million and authorized a new $25 million stock repurchase program.